CD4 and AIDS: The development and introduction of combinatory antiretroviral therapy (cART), which is a combination of three to four antiviral drugs targeting multiple stages of the viral replication cycle is critical in inhibiting HIV replication, maintaining CD4+ T cells at near-normal levels, and preventing onset of AIDS which has resulted in longer live-spans of the HIV-infected population (Moutouh et al., 1996).